BioNTech SE

BNTX

NASDAQ. Currency in USD

168.56 -6.69 ( -3.82% )

Real time prices: December 19

Date 2021 2020 2019 2018
Operating Cash Flow 889.70M -13.47M -198.54M -58.18M
Payments For Operating Activities - - - -
Proceeds From Operating Activities 889.70M -13.47M -198.54M -58.18M
Change In Operating Liabilities - - - -
Change In Operating Assets - - - -
Depreciation Depletion And Amortization 75.20M 38.74M 33.90M 21.98M
Capital Expenditures 154.00M 85.45M 71.08M 67.85M
Change In Receivables - - 0 0
Change In Inventory -438.40M -49.79M -5.80M -1.25M
Profit (or loss) - - - -
Cash Flow From Investment -566.10M -144.85M -77.11M -66.45M
Cash Flow From Financing 94.20M 894.73M 383.29M 365.18M
Proceeds From Repayments Of Short Term Debt - - - -
Payments For Repurchase Of Common Stock - - - -
Payments For Repurchase Of Equity - - - -
Payments For Repurchase Of Preferred Stock - - - -
Dividend Payout - - 0 0
Dividend Payout Common Stock - - 0 0
Dividend Payout Preferred Stock - - - -
Proceeds From Issuance Of Common Stock - - 375.35M 361.73M
Proceeds From Issuance Of Long Term Debt And Capital Securities - - - -
Proceeds From Issuance Of Preferred Stock - - - -
Proceeds From Repurchase Of Equity - - 375.35M 361.73M
Proceeds From Sale Of Treasury Stock - - - -
Change In Cash And Cash Equivalents - - 0 0
Change In Exchange Rate - - 0 0
Free Cash Flow 735.70M -98.92M -269.62M -126.03M